GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Equity-to-Asset

Instadose Pharma (Instadose Pharma) Equity-to-Asset : 0.78 (As of Feb. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Instadose Pharma's Total Stockholders Equity for the quarter that ended in Feb. 2022 was $28.05 Mil. Instadose Pharma's Total Assets for the quarter that ended in Feb. 2022 was $36.14 Mil.

The historical rank and industry rank for Instadose Pharma's Equity-to-Asset or its related term are showing as below:

INSD's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Instadose Pharma Equity-to-Asset Historical Data

The historical data trend for Instadose Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Equity-to-Asset Chart

Instadose Pharma Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21
Equity-to-Asset
Get a 7-Day Free Trial -12.00 - - - -

Instadose Pharma Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.78

Competitive Comparison of Instadose Pharma's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instadose Pharma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's Equity-to-Asset falls into.



Instadose Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Instadose Pharma's Equity to Asset Ratio for the fiscal year that ended in Nov. 2021 is calculated as

Equity to Asset (A: Nov. 2021 )=Total Stockholders Equity/Total Assets
=-0.165/0
=

Instadose Pharma's Equity to Asset Ratio for the quarter that ended in Feb. 2022 is calculated as

Equity to Asset (Q: Feb. 2022 )=Total Stockholders Equity/Total Assets
=28.053/36.142
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instadose Pharma  (OTCPK:INSD) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Instadose Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Instadose Pharma (Instadose Pharma) Business Description

Traded in Other Exchanges
N/A
Address
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.

Instadose Pharma (Instadose Pharma) Headlines

From GuruFocus